Different Mutation Tolerance of Lentiviral (HIV-1) and Deltaretroviral (BLV and HTLV) Protease Precursors
The bovine leukemia virus (BLV) and the human T-lymphothropic viruses (HTLVs) are members of the deltaretrovirus genus of <i>Retroviridae</i> family. An essential event of the retroviral life cycle is the processing of the polyproteins by the viral protease (PR); consequently, these enzy...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/14/9/1888 |
_version_ | 1797481407812993024 |
---|---|
author | János András Mótyán Norbert Kassay Krisztina Matúz József Tőzsér |
author_facet | János András Mótyán Norbert Kassay Krisztina Matúz József Tőzsér |
author_sort | János András Mótyán |
collection | DOAJ |
description | The bovine leukemia virus (BLV) and the human T-lymphothropic viruses (HTLVs) are members of the deltaretrovirus genus of <i>Retroviridae</i> family. An essential event of the retroviral life cycle is the processing of the polyproteins by the viral protease (PR); consequently, these enzymes became important therapeutic targets of the anti-retroviral drugs. As compared to human immunodeficiency viruses (HIVs), the deltaretroviruses have a different replication strategy, as they replicate predominantly in the DNA form, by forcing the infected cell to divide, unlike HIV-1, which replicates mainly by producing a vast number of progeny virions and by reinfection. Due to bypassing the error-prone reverse transcription step of replication, the PRs of deltaretroviruses did not undergo such extensive evolution as HIV PRs and remained more highly conserved. In this work, we studied the abilities of wild-type and modified BLV, HTLV (type 1, 2 and 3), and HIV-1 PRs (fused to an N-terminal MBP tag) for self-processing. We designed a cleavage site mutant MBP-fused BLV PR precursor as well, this recombinant enzyme was unable for self-proteolysis, the MBP fusion tag decreased its catalytic efficiency but showed an unusually low K<sub>i</sub> for the IB-268 protease inhibitor. Our results show that the HTLV and BLV deltaretrovirus PRs exhibit lower mutation tolerance as compared to HIV-1 PR, and are less likely to retain their activity upon point mutations at various positions, indicating a higher flexibility of HIV-1 PR in tolerating mutations under selective pressure. |
first_indexed | 2024-03-09T22:14:08Z |
format | Article |
id | doaj.art-3ca13decee4f49d1b9be6172f299dfb2 |
institution | Directory Open Access Journal |
issn | 1999-4915 |
language | English |
last_indexed | 2024-03-09T22:14:08Z |
publishDate | 2022-08-01 |
publisher | MDPI AG |
record_format | Article |
series | Viruses |
spelling | doaj.art-3ca13decee4f49d1b9be6172f299dfb22023-11-23T19:25:49ZengMDPI AGViruses1999-49152022-08-01149188810.3390/v14091888Different Mutation Tolerance of Lentiviral (HIV-1) and Deltaretroviral (BLV and HTLV) Protease PrecursorsJános András Mótyán0Norbert Kassay1Krisztina Matúz2József Tőzsér3Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, HungaryDepartment of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, HungaryDepartment of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, HungaryDepartment of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, HungaryThe bovine leukemia virus (BLV) and the human T-lymphothropic viruses (HTLVs) are members of the deltaretrovirus genus of <i>Retroviridae</i> family. An essential event of the retroviral life cycle is the processing of the polyproteins by the viral protease (PR); consequently, these enzymes became important therapeutic targets of the anti-retroviral drugs. As compared to human immunodeficiency viruses (HIVs), the deltaretroviruses have a different replication strategy, as they replicate predominantly in the DNA form, by forcing the infected cell to divide, unlike HIV-1, which replicates mainly by producing a vast number of progeny virions and by reinfection. Due to bypassing the error-prone reverse transcription step of replication, the PRs of deltaretroviruses did not undergo such extensive evolution as HIV PRs and remained more highly conserved. In this work, we studied the abilities of wild-type and modified BLV, HTLV (type 1, 2 and 3), and HIV-1 PRs (fused to an N-terminal MBP tag) for self-processing. We designed a cleavage site mutant MBP-fused BLV PR precursor as well, this recombinant enzyme was unable for self-proteolysis, the MBP fusion tag decreased its catalytic efficiency but showed an unusually low K<sub>i</sub> for the IB-268 protease inhibitor. Our results show that the HTLV and BLV deltaretrovirus PRs exhibit lower mutation tolerance as compared to HIV-1 PR, and are less likely to retain their activity upon point mutations at various positions, indicating a higher flexibility of HIV-1 PR in tolerating mutations under selective pressure.https://www.mdpi.com/1999-4915/14/9/1888human T-lymphotropic virusbovine leukemia virushuman immunodeficiency virusHTLVBLVHIV-1 |
spellingShingle | János András Mótyán Norbert Kassay Krisztina Matúz József Tőzsér Different Mutation Tolerance of Lentiviral (HIV-1) and Deltaretroviral (BLV and HTLV) Protease Precursors Viruses human T-lymphotropic virus bovine leukemia virus human immunodeficiency virus HTLV BLV HIV-1 |
title | Different Mutation Tolerance of Lentiviral (HIV-1) and Deltaretroviral (BLV and HTLV) Protease Precursors |
title_full | Different Mutation Tolerance of Lentiviral (HIV-1) and Deltaretroviral (BLV and HTLV) Protease Precursors |
title_fullStr | Different Mutation Tolerance of Lentiviral (HIV-1) and Deltaretroviral (BLV and HTLV) Protease Precursors |
title_full_unstemmed | Different Mutation Tolerance of Lentiviral (HIV-1) and Deltaretroviral (BLV and HTLV) Protease Precursors |
title_short | Different Mutation Tolerance of Lentiviral (HIV-1) and Deltaretroviral (BLV and HTLV) Protease Precursors |
title_sort | different mutation tolerance of lentiviral hiv 1 and deltaretroviral blv and htlv protease precursors |
topic | human T-lymphotropic virus bovine leukemia virus human immunodeficiency virus HTLV BLV HIV-1 |
url | https://www.mdpi.com/1999-4915/14/9/1888 |
work_keys_str_mv | AT janosandrasmotyan differentmutationtoleranceoflentiviralhiv1anddeltaretroviralblvandhtlvproteaseprecursors AT norbertkassay differentmutationtoleranceoflentiviralhiv1anddeltaretroviralblvandhtlvproteaseprecursors AT krisztinamatuz differentmutationtoleranceoflentiviralhiv1anddeltaretroviralblvandhtlvproteaseprecursors AT jozseftozser differentmutationtoleranceoflentiviralhiv1anddeltaretroviralblvandhtlvproteaseprecursors |